Removing aspirin from STEMI patients - Can we improve bleeding without compromising on results?

Sponsored by Sinomed B.V.
Coronary Interventions

Join us if you want

  • To understand why monotherapy following STEMI can be beneficial for patients
  • To understand why aspirin should be eliminated from post-PCI care, especially in the setting of STEMI
  • To learn about the ASET SUPREME study and what questions will be answered by this trial

Speakers: Victor Alfonso Jimenez Diaz, Yoshinobu Onuma, Joanna Wykrzykowska